From USFDA
Shilpa Medicare announced that the Company has received an approval from the United States Food & Drug Administration (USPDA) for AZACITIDINE - INJECTION ANDA of SEZ Formulations Facility situated at Jadcherla, near Hyderabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
